Bayer Roundup $7.25B Settlement Nears Final Decision - 65,000 Cancer Patients Must Act Now

The largest proposed class action settlement in herbicide litigation history is awaiting a single court ruling that could transform the legal landscape for Roundup weedkiller cancer claims. Bayer's proposed $7.25 billion settlement - which would cover tens of thousands of existing cancer claimants and potentially hundreds of thousands of future ones - had its fairness hearing in a Missouri state court on September 14, 2026. As of mid-October 2026, the presiding judge had not yet issued a written ruling, though a decision was described as expected soon. Meanwhile, a new jury trial against Bayer began in St. Louis on September 29, 2026, keeping the litigation squarely in the news.

What Is the Bayer Roundup Settlement?

Roundup is the world's top-selling herbicide. Its active ingredient, glyphosate, was classified in 2015 by the International Agency for Research on Cancer as "probably carcinogenic to humans." Since that classification, thousands of agricultural workers, landscapers, and homeowners have filed lawsuits claiming that prolonged Roundup exposure caused them to develop non-Hodgkin's lymphoma (NHL) and related blood cancers. Bayer AG inherited the litigation when it acquired Monsanto, Roundup's original maker, in 2018 for $63 billion.

In February 2026, Bayer proposed a settlement of up to $7.25 billion to resolve most current and future Roundup claims in a single class action proceeding. The agreement was given preliminary approval in March 2026. Payments would be structured over approximately 21 years and distributed on a tiered basis, with individual awards estimated to range from roughly $10,000 to more than $165,000, depending on factors such as age at diagnosis, cancer severity, and documented Roundup exposure.

What Changed After the Supreme Court's June 2026 Ruling

The legal terrain for Roundup plaintiffs changed significantly on June 25, 2026, when the U.S. Supreme Court ruled 7-2 in Monsanto Co. v. Durnell that the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA) preempts state-law failure-to-warn claims. This ruling means that plaintiffs can no longer successfully argue in state courts that Monsanto failed to warn users about Roundup's cancer risks, because federal law - which permits Roundup's continued sale - now supersedes those state claims.

The Durnell ruling narrows the legal avenues available to Roundup cancer victims pursuing individual state-court cases. As a result, plaintiffs who had built their lawsuits on warning-theory grounds must now pursue other legal theories - such as design defects or inadequate testing - or participate in the class settlement. For many of the approximately 65,000 outstanding Roundup claimants, the proposed $7.25 billion settlement has become the primary - and in many cases the only - realistic path to compensation.

Where Does the Case Stand in October 2026?

The fairness hearing was held September 14, 2026, before Missouri Circuit Court Judge Timothy Boyer. Several plaintiffs' law firms filed objections, arguing the settlement's payout tiers undervalue individual claims. The judge has not yet issued a written ruling as of mid-October 2026, though legal observers expect a decision in the coming weeks.

Separately, a jury trial involving three non-Hodgkin's lymphoma plaintiffs began in St. Louis on September 29, 2026. Because the Supreme Court's Durnell ruling foreclosed failure-to-warn arguments, those plaintiffs are pursuing design-defect and inadequate-testing theories. Their attorneys argue that Monsanto failed to adequately test Roundup before bringing it to market. Bayer's attorneys counter that plaintiffs cannot demonstrate glyphosate is unreasonably dangerous, given decades of regulatory review supporting the herbicide's safety. The trial's outcome may influence Judge Boyer's assessment of the settlement's fairness.

The opt-out deadline of August 21, 2026 has passed. Class members who did not formally opt out are bound by the settlement's terms upon final court approval.

Who May Qualify for Settlement Compensation?

The proposed settlement covers individuals who meet these general criteria:

• Were exposed to Roundup herbicide before February 17, 2026
• Have been diagnosed with a qualifying cancer, including:
• • Non-Hodgkin's lymphoma (NHL) and its subtypes - including diffuse large B-cell lymphoma (DLBCL), follicular lymphoma, mantle cell lymphoma, and Burkitt lymphoma
  • Chronic lymphocytic leukemia (CLL)

Both occupational users - farmers, agricultural workers, landscapers, and groundskeepers - and residential users who applied Roundup in home gardens or yards may be eligible. Supporting documentation typically includes medical records confirming diagnosis and evidence of Roundup exposure, such as purchase receipts, employment records, or photographs.

What Should Roundup Exposure Victims Do Now?

1. Consult an attorney promptly. State deadlines to file a personal injury lawsuit range from one to three years from diagnosis or from when harm was reasonably discoverable. Missing these deadlines can permanently extinguish legal rights.
2. Gather records. Collect medical records confirming your cancer diagnosis and documentation of Roundup use - receipts, farm or work records, employment documents, or photographs.
3. Monitor the official settlement website. Once final approval is entered, already-diagnosed claimants will have 180 days to register. Visit weedkillerclass.com for official updates on the ruling.
4. Know your future claim rights. Individuals diagnosed after the settlement is finalized will also be covered. They have up to six years from their diagnosis date - or until the 16th annual settlement payment - to file a claim.

Attorneys who handle Roundup cases generally work on a contingency basis, meaning no upfront fees are charged. Be cautious of any firm requesting payment before a recovery is made.